Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about REACTIVE OXYGEN SPECIES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | REACTIVE OXYGEN SPECIES |
| Summary | # [Reactive Oxygen Species](/entities/reactive-oxygen-species) ([ROS](/entities/reactive-oxygen-species)) ## Introduction [Reactive Oxygen Species](/entities/reactive-oxygen-species) (Ros) is an impo |
| Key Genes/Proteins | RTN3, SESN2, SNCA, SNCAIP, SQSTM1, P62 |
| Related Diseases | ALS |
Knowledge base pages for this entity
graph TD
REACTIVE_OXYGEN_SPECIES["REACTIVE OXYGEN SPECIES"]
REACTIVE_OXYGEN_SPECIES -->|"modulates"| DUBS["DUBS"]
REACTIVE_OXYGEN_SPECIES -->|"modulates"| DUB["DUB"]
REACTIVE_OXYGEN_SPECIES -->|"involved_in"| Neutrophil_Extracellular_Traps["Neutrophil Extracellular Traps"]
REACTIVE_OXYGEN_SPECIES -.biomarker for.-> Hypertrophic_Scar["Hypertrophic Scar"]
REACTIVE_OXYGEN_SPECIES -->|"modulates"| Catalytic_Cysteine["Catalytic Cysteine"]
REACTIVE_OXYGEN_SPECIES -->|"contributes to"| amyloid_beta["amyloid beta"]
REACTIVE_OXYGEN_SPECIES -->|"activates"| Separating_Microneedles["Separating Microneedles"]
REACTIVE_OXYGEN_SPECIES -->|"contributes to"| Learning_and_Memory_Deficits["Learning and Memory Deficits"]
REACTIVE_OXYGEN_SPECIES -->|"contributes to"| Protein_Accumulation["Protein Accumulation"]
REACTIVE_OXYGEN_SPECIES -->|"activates"| mitochondrial_dysfunction["mitochondrial dysfunction"]
HSPA1A["HSPA1A"] -->|"inhibits"| REACTIVE_OXYGEN_SPECIES
Antioxidants["Antioxidants"] -->|"downregulates"| REACTIVE_OXYGEN_SPECIES
PGC1A["PGC1A"] -->|"regulates"| REACTIVE_OXYGEN_SPECIES
SLC7A11["SLC7A11"] -->|"downregulates"| REACTIVE_OXYGEN_SPECIES
MT1["MT1"] -->|"modulates"| REACTIVE_OXYGEN_SPECIES
MT2["MT2"] -->|"modulates"| REACTIVE_OXYGEN_SPECIES
Dolutegravir["Dolutegravir"] -->|"upregulates"| REACTIVE_OXYGEN_SPECIES
Lactic_Acid["Lactic Acid"] -->|"downregulates"| REACTIVE_OXYGEN_SPECIES
GJA1_20k["GJA1-20k"] -->|"downregulates"| REACTIVE_OXYGEN_SPECIES
Mitophagic_Flux_Inhibition["Mitophagic Flux Inhibition"] -->|"causes"| REACTIVE_OXYGEN_SPECIES| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer's Disease | contributes_to | disease | 0.95 |
| Neurodegeneration | causes | process | 0.95 |
| Parkinson Disease | contributes_to | disease | 0.95 |
| PANoptosis | activates | process | 0.90 |
| Acute Kidney Injury | associated_with | disease | 0.90 |
| Neurodegeneration | contributes_to | process | 0.90 |
| AMPK-mTOR Pathway | activates | pathway | 0.90 |
| DNM1L | phosphorylates | protein | 0.90 |
| GSDME | cleaves | protein | 0.88 |
| Oxidative Stress | causes | process | 0.88 |
| ZBP1 | activates | protein | 0.85 |
| chondrocytes | associated_with | cell_type | 0.85 |
| cytoskeletal proteins | degrades | protein | 0.85 |
| Amyloid Beta Aggregation | upregulates | process | 0.85 |
| Mitochondrial Impairment | causes | phenotype | 0.85 |
| TFEB Nuclear Translocation | mediates | mechanism | 0.85 |
| Hypertrophic Scar | drives | disease | 0.85 |
| glioblastoma | treats | disease | 0.85 |
| amyloid beta | contributes_to | protein | 0.80 |
| proinflammatory cytokines | increases | compound | 0.80 |
| cognitive deficits | causes | phenotype | 0.80 |
| Diabetes-Associated Cognitive Impairment | contributes_to | disease | 0.80 |
| Senescence | contributes_to | process | 0.80 |
| P53 | upstream_of | gene | 0.80 |
| Stimuli-responsive nanoplatforms | associated_with | compound | 0.75 |
| oxidative damage | activates | process | 0.70 |
| neuronal damage | activates | process | 0.70 |
| Mitochondrial dysfunction | activates | process | 0.70 |
| Oxidative stress | activates | process | 0.70 |
| BBB disruption | activates | process | 0.70 |
| neuroapoptosis | activates | process | 0.70 |
| brain damage | causes | process | 0.70 |
| Oxidative stress | causes | process | 0.70 |
| Brain cell death | activates | process | 0.70 |
| mitochondrial fragmentation | activates | process | 0.70 |
| mitochondrial dysfunction | activates | process | 0.70 |
| oxidative stress | activates | process | 0.70 |
| NUCLEUS | activates | concept | 0.50 |
| ENDOPLASMIC RETICULUM | activates | concept | 0.50 |
| RAPAMYCIN | activates | concept | 0.50 |
| PEROXISOME | activates | concept | 0.50 |
| Proteins | activates | protein | 0.50 |
| MONOCYTES | interacts_with | concept | 0.50 |
| HEPATOCYTES | interacts_with | concept | 0.50 |
| DENDRITIC CELLS | interacts_with | concept | 0.50 |
| Cellular Senescence | activates | cell_type | 0.50 |
| α-SYNUCLEIN | causes | concept | 0.50 |
| AUTOPHAGOSOME | activates | concept | 0.50 |
| Proteins | causes | protein | 0.50 |
| WNT SIGNALING | inhibits | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| DTG | upregulates | entity | 0.95 |
| Ferroptosis | causes | process | 0.95 |
| Celastrol | promotes | compound | 0.95 |
| TRPML1-TFEB pathway | inhibits | pathway | 0.93 |
| Type I photodynamic therapy | associated_with | process | 0.92 |
| curcumin | inhibits | drug | 0.90 |
| HSPA1A | suppresses | gene | 0.90 |
| GJA1-20k | suppresses | protein | 0.90 |
| selenium-containing compound | associated_with | compound | 0.90 |
| stroke | causes | disease | 0.90 |
| Mitochondrial Dysfunction | causes | process | 0.90 |
| PPARGC1A | regulates | gene | 0.90 |
| DTG | upregulates | drug | 0.90 |
| FOXO1 | regulates | gene | 0.90 |
| Rg1 | associated_with | compound | 0.90 |
| Icariin | inhibits | compound | 0.90 |
| Crocetin | suppresses | compound | 0.90 |
| Dolutegravir | upregulates | drug | 0.88 |
| SLC15A3 | regulates | protein | 0.85 |
| PPARGC1A | modulates | gene | 0.85 |
| Quercetier | downregulates | compound | 0.85 |
| 2,2,6,6-tetramethylpiperidine-1-oxyl | associated_with | compound | 0.85 |
| Paeoniflorin | modulates | compound | 0.85 |
| Photodynamic Therapy | mediates | process | 0.85 |
| CREBBP | regulates | gene | 0.85 |
| AKT | modulates | protein | 0.85 |
| ischemia-reperfusion injury | increases | disease | 0.80 |
| APOE | increases | gene | 0.80 |
| SIRT3 | regulates | gene | 0.80 |
| Egcg | modulates | compound | 0.80 |
| AMYLOID-BETA | associated_with | protein | 0.80 |
| PRKAA1 | regulates | gene | 0.80 |
| Tryptamine | associated_with | compound | 0.80 |
| 5-fluorouracil | suppresses | drug | 0.80 |
| MICROGLIA | releases | cell_type | 0.80 |
| ERK | inhibits | protein | 0.75 |
| autophagy | regulates | process | 0.70 |
| lipid droplet formation | activates | process | 0.70 |
| Tau protein | activates | protein | 0.70 |
| Amyloid β | activates | protein | 0.70 |
| intraocular pressure | activates | process | 0.70 |
| ethanol | activates | drug | 0.70 |
| melatonin | inhibits | drug | 0.70 |
| Ischemic stroke | associated_with | disease | 0.70 |
| Ischemia/reperfusion injury | activates | process | 0.70 |
| amyloid beta | activates | protein | 0.70 |
| hyperphosphorylated tau | activates | protein | 0.70 |
| Ginsenoside Rb1 | inhibits | drug | 0.70 |
| mitochondrial dysfunction | activates | process | 0.70 |
| HSPA1A | activates | protein | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||